{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:59:24Z","timestamp":1783141164559,"version":"3.54.6"},"update-to":[{"DOI":"10.1016\/j.bpobgyn.2023.102350","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}}],"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020956","name":"Merck Healthcare KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bpobgyn.2023.102350","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T17:56:42Z","timestamp":1683827802000},"page":"102350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["WITHDRAWN:\u00c2\u00a0Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35\u201340 years: A German database study"],"prefix":"10.1016","volume":"89","author":[{"given":"A.P.","family":"Bielfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Schwarze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Verpillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lispi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Chuderland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"D'Hooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Krussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102350_bib2","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/humrep\/deab065","article-title":"Reduced FSH and LH action: implications for medically assisted reproduction","volume":"36","author":"Bosch","year":"2021","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib3","first-page":"25","article-title":"Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea","volume":"83","author":"Laughlin","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib4","series-title":"Endotext","article-title":"Hypogonadotropic hypogonadism (HH) and gonadotropin therapy","author":"Hayes","year":"2000"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.rbmo.2015.06.002","article-title":"Randomized trial comparing luteinizing hormone supplementation timing strategies in older women undergoing ovarian stimulation","volume":"31","author":"Behre","year":"2015","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102350_bib6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.rbmo.2012.02.009","article-title":"Array CGH analysis shows that aneuploidy is not related to the number of embryos generated","volume":"24","author":"Ata","year":"2012","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102350_bib7","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.fertnstert.2016.02.028","article-title":"Impact of female age and nulligravidity on fecundity in an older reproductive age cohort","volume":"105","author":"Steiner","year":"2016","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102350_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/er.2009-0006","article-title":"Ovarian aging: mechanisms and clinical consequences","volume":"30","author":"Broekmans","year":"2009","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.bpobgyn.2023.102350_bib9","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1210\/en.2007-0046","article-title":"Rising follicle-stimulating hormone levels with age accelerate female reproductive failure","volume":"148","author":"McTavish","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fendo.2018.00216","article-title":"In\u00a0Vivo and in\u00a0vitro impact of carbohydrate variation on human follicle-stimulating hormone function","volume":"9","author":"Bousfield","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mce.2015.12.008","article-title":"Follicle-stimulating hormone potentiates the steroidogenic activity of chorionic gonadotropin and the anti-apoptotic activity of luteinizing hormone in human granulosa-lutein cells in\u00a0vitro","volume":"422","author":"Casarini","year":"2016","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.fertnstert.2010.10.021","article-title":"Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis","volume":"95","author":"Bosch","year":"2011","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102350_bib13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/humrep\/den061","article-title":"Change, change, change: hormonal actions depend on changes in blood levels","volume":"23","author":"Kol","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.907249","article-title":"Luteinizing hormone supplementation in women with hypogonadotropic hypogonadism seeking fertility care: insights from a narrative review","volume":"13","author":"Di Segni","year":"2022","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12958-022-01014-0","volume":"20","author":"Zhang","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102350_bib16","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1530\/eje.0.1340357","article-title":"Gonadotropins and gonadotropin receptors during the perimenopause","volume":"134","author":"Vihko","year":"1996","journal-title":"Eur J Endocrinol"},{"issue":"8 Pt 1","key":"10.1016\/j.bpobgyn.2023.102350_bib18","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/clinchem\/41.8.1139","article-title":"Immunometric assays of luteinizing hormone (LH): differences in recognition of plasma LH by anti-intact and beta-subunit-specific antibodies in various physiological and pathophysiological situations","volume":"41","author":"Mitchell","year":"1995","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-2004-831896","article-title":"Inhibins, activins, and follistatin in the aging female and male","volume":"22","author":"Hurwitz","year":"2004","journal-title":"Semin Reprod Med"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102350_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0378-5122(84)90015-X","article-title":"Decrease in luteinizing hormone biological activity\/immunoreactivity ratio in elderly men","volume":"5","author":"Marrama","year":"1984","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102350_bib22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10815-022-02456-6","article-title":"Regulation of antral follicular growth by an interplay between gonadotropins and their receptors","volume":"39","author":"Casarini","year":"2022","journal-title":"J\u00a0Assist Reprod Genet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12958-021-00759-4","article-title":"Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Conforti","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2023.102350_bib24","first-page":"996","volume":"35","author":"Carone","year":"2012","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12958-019-0460-4","article-title":"The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis","volume":"17","author":"Conforti","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41118-020-00108-0","article-title":"European countries with delayed childbearing are not those with lower fertility","volume":"77","author":"\u00c9","year":"2021","journal-title":"Genus"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102350_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.11622\/smedj.2014081","article-title":"Female ageing and reproductive outcome in assisted reproduction cycles","volume":"55","author":"Tan","year":"2014","journal-title":"Singap Med J"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102350_bib28","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/humrep\/del075","article-title":"Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE","volume":"21","author":"Andersen","year":"2006","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.bpobgyn.2023.102350_bib29","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/humrep\/dey242","article-title":"ART in europe, 2014: results generated from European registries by ESHRE: the European IVF-monitoring consortium (EIM) for the European society of human reproduction and Embryology (ESHRE)","volume":"33","author":"De Geyter","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.587051","article-title":"Improving reporting of clinical studies using the POSEIDON criteria: POSORT guidelines","volume":"12","author":"Esteves","year":"2021","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102350_bib31","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.fertnstert.2009.11.018","article-title":"Measuring outcomes in fertility trials: can we rely on clinical pregnancy rates?","volume":"94","author":"Clarke","year":"2010","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102350_bib32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.fertnstert.2018.04.037","article-title":"Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients","volume":"109","author":"Mol","year":"2018","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/eb-2017-102701","article-title":"The limitations of using randomised controlled trials as a basis for developing treatment guidelines","volume":"21","author":"Mulder","year":"2018","journal-title":"Evid Base Ment Health"},{"issue":"11","key":"10.1016\/j.bpobgyn.2023.102350_bib34","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s12325-018-0805-y","article-title":"Interpretation and impact of real-world clinical data for the practicing clinician","volume":"35","author":"Blonde","year":"2018","journal-title":"Adv Ther"},{"issue":"8","key":"10.1016\/j.bpobgyn.2023.102350_bib35","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/humrep\/deaa138","article-title":"Time as an outcome measure in fertility-related clinical studies: long-awaited","volume":"35","author":"Sunkara","year":"2020","journal-title":"Hum Reprod"},{"issue":"34","key":"10.1016\/j.bpobgyn.2023.102350_bib36","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.3346\/jkms.2018.33.e213","article-title":"Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records","volume":"33","author":"Kim","year":"2018","journal-title":"J\u00a0Kor Med Sci"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102350_bib37","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1055\/s-0042-108576","article-title":"The German IVF register as an instrument to document assisted reproductive Technologies","volume":"76","author":"Kadi","year":"2016","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.rbmo.2016.11.010","article-title":"'Model' versus 'everyday' patients: can randomized controlled trial data really be applied to the clinic?","volume":"34","author":"Hershkop","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib39","first-page":"29","article-title":"The German IVF-Registry - D\u00b7I\u00b7R","volume":"10","author":"B\u00fchler","year":"2013","journal-title":"Journal fur Reproduktionsmedizin und Endokrinologie"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib40","first-page":"217","article-title":"D.I.R-Annual","volume":"15","author":"Blumenauer","year":"2017","journal-title":"J Reproduktionsmed Endokrinol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102350_bib41","first-page":"272","article-title":"D.I.R-Annual","volume":"16","author":"Blumenauer","year":"2018","journal-title":"Journal fur Reproduktionsmedizin und Endokrinologie"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102350_bib42","first-page":"196","article-title":"D.I.R-Annual","volume":"17","author":"Blumenauer","year":"2019","journal-title":"Journal fur Reproduktionsmedizin und Endokrinologie"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/humrep\/dez258","article-title":"A\u00a0systematic review of the quality of clinical prediction models in in\u00a0vitro fertilisation","volume":"35","author":"Ratna","year":"2020","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102350_bib44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.fertnstert.2021.09.015","article-title":"Predicting personalized cumulative live birth following in\u00a0vitro fertilization","volume":"117","author":"McLernon","year":"2022","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.bpobgyn.2023.102350_bib45","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/humrep\/dey263","article-title":"Predicting the cumulative chance of live birth over multiple complete cycles of in\u00a0vitro fertilization: an external validation study","volume":"33","author":"Leijdekkers","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple hypothesis testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0Roy Stat Soc B"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102350_bib47","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in\u00a0vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.bpobgyn.2023.102350_bib48","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/humrep\/dev149","article-title":"Sub-optimal responders following controlled ovarian stimulation: an overlooked group?","volume":"30","author":"Polyzos","year":"2015","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12958-021-00768-3","article-title":"Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany","volume":"19","author":"B\u00fchler","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib50","doi-asserted-by":"crossref","first-page":"S493","DOI":"10.1016\/j.fertnstert.2013.07.349","article-title":"A\u00a0life birth predictive model after in\u00a0vitro fertilization (ivf) may have a fair discrimination: results of a multicenter external validation based on 15039 ivf cycles","volume":"100","author":"Arvis","year":"2013","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib51","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.fertnstert.2014.05.020","article-title":"A\u00a0prediction model for live birth and multiple births within the first three cycles of assisted reproductive technology","volume":"102","author":"Luke","year":"2014","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/humrep\/dev336","article-title":"Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle data from 178,898 women","volume":"31","author":"McLernon","year":"2016","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib53","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.rbmo.2020.08.035","article-title":"Effect of recombinant LH supplementation on cumulative live birth rate compared with FSH alone in poor ovarian responders: a large, real-world study","volume":"42","author":"Arvis","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib54","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3389\/fendo.2019.00814","article-title":"The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists","volume":"10","author":"Esteves","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7827-7-101","article-title":"Biological versus chronological ovarian age: implications for assisted reproductive technology","volume":"7","author":"Alviggi","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib56","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1477-7827-12-128","article-title":"Human steroidogenesis: implications for controlled ovarian stimulation with exogenous gonadotropins","volume":"12","author":"Andersen","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102350_bib57","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0015-0282(16)58203-X","article-title":"Evidence for diminished midcycle ovarian androgen production in older reproductive aged women","volume":"65","author":"Mushayandebvu","year":"1996","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.bpobgyn.2023.102350_bib58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/molehr\/4.7.631","article-title":"Glycoform composition of serum gonadotrophins through the normal menstrual cycle and in the post-menopausal state","volume":"4","author":"Anobile","year":"1998","journal-title":"Mol Hum Reprod"},{"issue":"4","key":"10.1016\/j.bpobgyn.2023.102350_bib59","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/humrep\/16.4.599","article-title":"Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: I. Gondatrophins are synthesized and released in multiple molecular forms","volume":"16","author":"Ulloa-Aguirre","year":"2001","journal-title":"A\u00a0matter of fact. Human Reproduction."},{"issue":"11","key":"10.1016\/j.bpobgyn.2023.102350_bib60","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1210\/jc.2007-1342","article-title":"Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men","volume":"92","author":"Wide","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102350_bib61","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1210\/er.2018-00065","article-title":"Two hormones for one receptor: evolution, biochemistry, actions, and pathophysiology of LH and hCG","volume":"39","author":"Casarini","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib62","article-title":"LH increases the response to FSH in granulosa-lutein cells from sub\/poor-responder patients in\u00a0vitro","author":"Sperduti","year":"2022","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib63","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.fertnstert.2006.06.059","article-title":"Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in\u00a0vitro fertilization procedures","volume":"87","author":"Ruvolo","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12958-015-0080-6","article-title":"Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population","volume":"13","author":"Revelli","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2023.102350_bib65","first-page":"1507","article-title":"Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group","volume":"83","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7827-12-17","article-title":"Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis","volume":"12","author":"Lehert","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102350_bib67","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1472-6483(10)61610-0","article-title":"Use of recombinant LH in a group of unselected IVF patients","volume":"5","author":"Lisi","year":"2002","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102350_bib68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1472-6483(10)61643-4","article-title":"Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study","volume":"8","author":"Humaidan","year":"2004","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"10.1016\/j.bpobgyn.2023.102350_bib69","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/09513590903215516","article-title":"LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels","volume":"26","author":"Pezzuto","year":"2010","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102350_bib70","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.fertnstert.2004.06.041","article-title":"Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques","volume":"82","author":"Ferraretti","year":"2004","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.bpobgyn.2023.102350_bib71","first-page":"544","article-title":"Efficacy and safety of follitropin alfa\/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders","volume":"32","author":"Humaidan","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib72","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fendo.2019.00282","article-title":"An observational retrospective cohort trial on 4,828 IVF cycles evaluating different low prognosis patients following the POSEIDON criteria","volume":"10","author":"Levi-Setti","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib73","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bpobgyn.2022.01.009","volume":"85","author":"Koloda","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.rbmo.2018.03.013","article-title":"Predicting live birth for poor ovarian responders: the PROsPeR concept","volume":"37","author":"Lehert","year":"2018","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"10.1016\/j.bpobgyn.2023.102350_bib75","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A\u00a0new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Poseidon","year":"2016","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/birt.12089","article-title":"Characteristics of primiparous women of advanced age and their partners: a homogenous or heterogenous group?","volume":"41","author":"Guedes","year":"2014","journal-title":"Birth"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib77","series-title":"Vital statistics of the United States","author":"National Center for Health Statistics","year":"1980"},{"issue":"1","key":"10.1016\/j.bpobgyn.2023.102350_bib78","first-page":"1","article-title":"Births: final data for 2009","volume":"60","author":"Martin","year":"2011","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib79","series-title":"Eurostat. Older mothers - European commission","year":"2022"},{"key":"10.1016\/j.bpobgyn.2023.102350_bib80","series-title":"WHO laboratory manual for the examination and processing of human semen","author":"Who","year":"2021"}],"updated-by":[{"DOI":"10.1016\/j.bpobgyn.2023.102350","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}},{"DOI":"10.1016\/j.bpobgyn.2023.102395","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693423000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693423000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:14:18Z","timestamp":1761498858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693423000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":80,"alternative-id":["S1521693423000500"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2023.102350","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WITHDRAWN:\u00c2\u00a0Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35\u201340 years: A German database study","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2023.102350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102350"}}